Indo Borax Q1 Standalone Net Profit Surges to 163M Rupees vs 100M YoY

Market snapshot: Indo Borax & Chemicals reported strong financial performance for the first quarter ended June 30, 2026. The standalone net profit grew 63% YoY to 163M Rupees, while EBITDA margins expanded to 28.1%.

Data Snapshot

• Standalone Net Profit increased to ₹16.3 crore from ₹10 crore in the same period last year.
• Consolidated EBITDA rose to ₹19.8 crore, representing a 62.16% increase compared to ₹12.21 crore in the previous year's corresponding quarter.
• EBITDA margin expanded by 530 basis points to 28.1% from 22.8% YoY.

What's Changed

• Standalone net profit surged 63% YoY (derived: ₹16.3 cr vs ₹10 cr), indicating strong bottom-line improvement.
• Consolidated EBITDA margins grew by 530 bps YoY to 28.1% due to enhanced capacity utilization and cost control.
• Consolidated revenues increased by 31.34% YoY to ₹70.36 crore from ₹53.57 crore.

Key Takeaways

• Robust top-line performance: Consolidated operating income expanded to ₹70.36 crore, driven by healthy demand for boron-based chemicals.
• Margin acceleration: Operational efficiencies pushed the EBITDA margin up to 28.1% from 22.8% in Q1 FY26.
• Strong balance sheet: The company remains almost debt-free, maintaining a healthy liquidity position.

SAHI Perspective

Indo Borax has delivered a stellar start to FY27, showcasing its capability to capitalize on growing domestic chemical demand. The massive margin expansion reflects strong pricing power and improved operational efficiencies, defying industry-wide margin compression trends. However, investors must monitor feedstock supply risks, as its raw materials are concentrated in select global regions like Turkey.

Market Implications

The stellar earnings performance is likely to boost investor confidence, especially given the company's solid dividend history and almost debt-free status. The stock's valuation, trading at approximately 25.55x P/E, appears reasonable relative to the broader chemical industry average of over 52x, suggesting potential room for rerating.

Trading Signals

Market Bias: Bullish

Strong YoY earnings growth with a 63% increase in standalone net profit and 530 bps EBITDA margin expansion indicates robust short-term momentum.

Overweight: Chemicals

Trigger Factors:

• Movement of raw material costs (feedstock sourced from Turkey/South America)
• NCLT approval progress for the amalgamation of Indoborax Infrastructure Private Limited

Time Horizon: Near-term (0-3 months)

Industry Context

The Indian boron-based chemicals sector is experiencing strong demand from diverse end-user industries including glass, ceramics, steel, agriculture, and detergents. Indo Borax maintains a significant domestic presence, supporting its capacity expansion and debottlenecking plans.

Key Risks to Watch

• Raw material sourcing concentration risks, with feedstock highly dependent on narrow global footprints (primarily Turkey and South America)
• Pledged promoter holding, with recent data showing 100% of promoter shares encumbered

Recent Developments

The company's Board of Directors approved the Scheme of Amalgamation of its wholly owned subsidiary, Indoborax Infrastructure Private Limited, on July 21, 2026, to consolidate resources and reduce compliance costs. In May 2026, the company declared a final dividend of 1000% (₹10/share) and a special dividend of 3000% (₹30/share) for FY26, with an ex-date of July 21, 2026.

Closing Insight

With robust capacity utilization, a strong balance sheet, and a pending subsidiary merger, Indo Borax & Chemicals is well-positioned to sustain its growth, provided it successfully manages its raw material supply chain risks.

High Performance Trading with SAHI.